Responses to Information about Psychosocial Consequences of Genetic Testing for Breast Cancer Susceptibility: Influences of Cancer Worry and Risk Perceptions
Restricted accessResearch articleFirst published online January, 2001
Responses to Information about Psychosocial Consequences of Genetic Testing for Breast Cancer Susceptibility: Influences of Cancer Worry and Risk Perceptions
We assessed the impact of information about psychosocial consequences of genetic testing for breast cancer susceptibility on interest in and beliefs about genetic testing, and whether these effects vary by levels of either cancer worry or perceived cancer risk. Women (N = 180) in an experimental study were randomly assigned to read one of four messages consisting of standard information along with information about either psychosocial advantages, potential disadvantages, both advantages and disadvantages, or no additional information. Women receiving only standard information reported higher interest in obtaining genetic testing than did women who received additional information about advantages, disadvantages, or both advantages and disadvantages. Cancer worry (but not perceived risk) predicted greater interest and more favorable beliefs about the benefits of testing. Beliefs that testing causes emotional distress were positively associated with worry and negatively associated with risk perceptions.
Andrykowski, M. A., Munn, R. K., & Studts, J. L. (1996). Interest in learning of personal genetic risk for cancer: A general population survey. Preventive Medicine, 25, 527–536.
2.
Baty, B. J., Venne, V. L., McDonald, J., Croyle, R. T., Halls, C., Nash, J. E., & Barkin, J. R. (1997). BRCA1 testing: Genetic counseling protocol development and counseling issues. Journal of Genetic Counseling, 6, 223–244.
3.
Biek, M., Wood, W., & Chaiken, S. (1996). Working knowledge, cognitive processing, and attitudes: On the determinants of bias. Personality and Social Psychology Bulletin, 22, 547–556.
4.
Calnan, M. W., & Moss, S. (1984). The health belief model and compliance with education given at a class in breast self-examination. Journal of Health and Social Behavior, 25, 198–210.
5.
Cameron, L. D. (1997). Screening for cancer: Illness worry and illness perceptions. In K. J. Petrie & J. Weinman (Eds.), Perceptions of illness and treatment: Current psychological research and applications (pp. 291–322). Reading, UK: Harwood Academic.
6.
Cameron, L., & Leventhal, H. (1995). Vulnerability beliefs, symptom experiences, and the processing of health threat information. Journal of Applied Social Psychology, 25, 1859–1883.
7.
Champion, V. (1991). The relationship of selected variables to breast cancer detection behaviors in women 35 and older. Oncology Nursing Forum, 18, 733–739.
8.
Claus, E. B., Risch, N., Thompson, W. D. (1994). Auto-somal dominant inheritance of early-onset breast cancer: Implications for risk perceptions. Cancer, 73, 643–651.
9.
Claus, E. B., Scheldkraut, J. M., Thompson, W. D., & Risch, N. J. (1996). The genetic attributable risk of breast and ovarian cancer. Cancer, 77, 2318–2324.
10.
Codori, A., Peterson, G. M., Miglioretti, E. K., Larkin, M. T., Bushey, C. Y., Brensinger, J. D., Johnson, K., Bacon, J. A., & Booker, S. V. (1999). Attitudes toward colon cancer gene testing: Factors Predicting Test Uptake. Cancer Epidemiology, Biomarkers and Prevention, 8, 345–351.
11.
Cohen, J., & Cohen, P. (1983). Applied multiple regression/correlation analysis for the behavioral sciences(2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
12.
Croyle, R. T., Dutson, D. S., Tran, V. T., & Sun, Y. (1995). Need for certainty and interest in genetic testing. Women's Health: Research on Gender, Behavior, and Policy, 1, 329–339.
13.
Croyle, R. T., & Lerman, C. (1993). Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Preventive Medicine, 22, 284–292.
14.
Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological Responses to BRCA1 mutation testing: Preliminary findings. Health Psychology, 16, 63–72.
15.
Croyle, R. T., & Williams, K. D. (1991). Reactions to medical diagnosis: The role of illness stereotypes. Basic and Applied Social Psychology, 12, 227–241.
16.
Diefenbach, M. A., & Leventhal, H. (1996). The common-sense model of illness representation: Theoretical and practical considerations. Journal of Social Distress and the Homeless, 5, 11–38.
17.
Diefenbach, M. A., Miller, S., & Daly, M. (1999). Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychology, 18, 532–536.
18.
Ellisen, L. W., & Haber, D. A. (1998). Hereditary breast cancer. Annual Review of Medicine, 49, 425–436.
19.
Epstein, S. (1994). Integration of the cognitive and the psychodynamic unconscious. American Psycholo-gist, 49, 709–724.
20.
Fodor, F. H., Westen, A., Bleiweiss, I. J., McCurdy, L. D., Walsh. M. M., Tartter, P. I., Brower, S. T., & Eng, C. M. (1998). Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. American Journal of Human Genetics, 63, 45–51.
21.
Gintner, G., Rectanus, E., Achord, K., & Parker, B. (1987). Parental history of hypertension and screening attendance: Effects of wellness appeal versus threat appeal. Health Psychology, 6, 432–444.
22.
Kash, K. M., Holland, J. C., Halper, M. S., & Miller, D. G. (1992). Psychological distress and surveillance behaviors of women with a family history of breast cancer. Journal of the National Cancer Institute, 84, 24–30.
23.
King, M. C., Rowell, S., & Love, S. M. (1993). Inherited breast and ovarian cancer: What are the risks? What are the choices?Journal of the American Medical Association, 269, 1975–1980.
24.
Lerman, C., Audrain, J., & Croyle, R. T. (1994). DNA-testing for heritable breast cancer risks: Lessons from traditional genetic counseling. Annals of Behavioral Medicine, 16, 327–333.
25.
Lerman, C., & Croyle, R. T. (1994). Psychological issues in genetic testing for breast cancer susceptibility. Archives of Internal Medicine, 154, 609–616.
26.
Lerman, C., & Croyle, R. T. (1995). Genetic testing for cancer predisposition: Behavioral science issues. Journal of the National Cancer Institute Monographs, 17, 63–66.
27.
Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast–ovarian cancer susceptibility. Journal of Clinical Oncology, 12, 843–850.
28.
Lerman, C., Daly, M., Sands, C., Balshem, A., Lust-bader, E., Heggan, T., Goldstein, L., James, J., & Engstrom, P. (1993). Mammography adherence and psychological distress among women at risk for breast cancer. Journal of the National Cancer Institute, 85, 1074–1080.
29.
Lerman, C., Lustbader, E., Rimer, B., Daly, M., Miller, S., Sands, C., & Balshem, A. (1995). Effects of individualized breast cancer risk counseling: A randomized trial. Journal of the National Cancer Institute, 87, 286–292.
30.
Lerman, C., & Schwarz, M. (1993). Adherence and psychological adjustment among women at high risk for breast cancer. Breast Cancer Research and Treatment, 28, 145–155.
31.
Lerman, C., Schwartz, M. D., Lin, T. H., Hughes, C., Narod, S., & Lynch, H. T. (1997). The influence of psychological distress on use of genetic testing for cancer risk. Journal of Consulting and Clinical Psychology, 65, 414–420.
32.
Leventhal, H., & Cameron, L. D. (1994). Persuasion and health. In T. Brock & S. Shavitt (Eds.), The psychology of persuasion. Chicago: Freeman, 219–249.
33.
Leventhal, H., Diefenbach, M. A., & Leventhal, E. A. (1992). Illness cognition: Using common sense to understand treatment adherence and affect-cognition interactions. Cognitive Therapy and Research, 16, 143–163.
34.
Leventhal, H., & Watts, J. (1966). Sources of resistance to fear-arousing communications on smoking and lung cancer. Journal of Personality, 34, 155–175.
35.
Marteau, T. M., Kidd, J., Cook, R., Michie, S., Johnston, M., Slack, J., & Shaw, R. W. (1991). Perceived risk not actual risk predicts uptake of amniocentesis. British Journal of Obstetrics and Gynaecology, 98, 282–286.
36.
McCaul, K. D., Branstetter, A. D., Schroeder, D. M., & Glasgow, R. E. (1996). What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychology, 15, 423–429.
37.
McCaul, K., Schroeder, D., & Reid, P. (1996). Breast cancer worry and screening: Some prospective data. Health Psychology, 15, 430–433.
38.
Millar, M. G., & Millar, K. (1995). Negative affective consequences of thinking about disease detection behaviors. Health Psychology, 14, 141–146.
39.
Smith, K. R., & Croyle, R. T. (1995). Attitudes toward genetic testing for colon cancer risk. American Journal of Public Health, 85, 1435–1438.
40.
Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1974). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists' Press.
41.
Stefanek, M. E., & Wilcox, P. (1991). First degree relatives of breast cancer patients: Screening practices and provision of risk information. Cancer Detection and Prevention, 15, 379–384.
42.
Streuwing, J. P., Hartge, P., Wackholder, S., Baker, S., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. D. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401–1407.
43.
Streuwing, J. P., Lerman, C., Kase, R. G., Giambarresi, T. R., & Tucker, M. A. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiology Biomarkers and Prevention, 4, 169–173.
44.
Taubes, G. (1992). NCI reverses one expert panel, sides with another. Science, 276, 127–128.
45.
Watson, D., & Clark, L. A. (1984). Negative affectivity: The disposition to experience aversive emotional states. Psychological Bulletin, 96, 465–490.
46.
Zuckerman, M., Knee, C. R., Hodgkins, H. J., & Miyake, K. (1995). Hypothesis confirmation: The joint effect of positive test strategy and acquiescence response set. Journal of Personality and Social Psychology, 68, 52–60.
